Michael E. Thase, MD
Michael E. Thase, MD, is the Editor-in-chief of Psychopharmacology Bulletin. Dr. Thase joined the faculty of the Perelman School of Medicine at the University of Pennsylvania in 2007 as Professor of Psychiatry after more than 27 years at the University of Pittsburgh Medical Center and the Western Psychiatric Institute and Clinic. Dr. Thase’s research focuses on the assessment and treatment of mood disorders, including studies of the differential therapeutics of both depression and bipolar affective disorder.
Dr. Thase obtained his medical degree at Ohio State University in 1979. He served as an intern, resident, and fellow at the Western Psychiatric Institute and Clinic before joining the University of Pittsburgh School of Medicine in 1983 as an assistant professor of psychiatry. Dr.Thase has directed the Depression Treatment and Research Program at Western Psychiatric Institute and Clinic since its inception in 1987.
A fellow of the American Psychiatric Association, Thase has received numerous honors in his field, including the Marie Eldredge Award from the American Psychiatric Association. He is also a member of many professional and scientific societies, including the American Medical Association, the American College of Neuropsychopharmacology, and the Society for Psychotherapy Research. He has co-authored more than 340 scientific articles and book chapters, as well as seven books. His published articles are featured in various journals, including Archives of General Psychiatry, the American Journal of Psychiatry, and the British Journal of Psychiatry. He is the editor-in-chief of Psychopharmacology Bulletin. A consultant and lecturer, Thase remains active in the community by giving numerous presentations at state hospitals. He also presents seminars for community hospitals and the Office of Education and Regional Programming.